Advertisement
PCVX Noticias de Forex
Vaxcyte Says FDA OK's IND Application Of VAX-31 For Prevention Of Invasive Pneumococcal Disease
Vaccine maker Vaxcyte, Inc. (PCVX) announced Thursday that the U.S. Food and Drug Administration (FDA) has cleared the Company's adult Investigational New Drug (IND) application for VAX-31, a 31-valent pneumococcal conjugate vaccine (PCV) candidate designed to prevent invasive pneumococcal disease (IPD).
RTTNews
|
hace 581
